Table 2

Characteristics of the patients with regard to the impact of VIT on work

 Impact of VIT on work
Positive
n=44
Negative or indifferent
n=137
p Value
Female, n (%)12 (27.3)31 (22.6)NS
Age, mean±SD49.7±11.746.8±10.3NS
VIT, n (%)
 Ongoing22 (50)100 (73)<0.01
 Concluded22 (50)37 (27)
Treated with VIT for, n (%)
Apis mellifera11 (25)48 (35)NS
Vespula sp.17 (38.6)49 (35.8)NS
Polistes sp.13 (22.7)31 (22.6)NS
Vespa crabro6 (13.6)9 (6.6)NS
Mueller reaction grade, n (%)
 I7 (15.9)26 (19)NS
 II6 (13.6)28 (20.4)
 III12 (27.3)25 (18.2)
 IV19 (43.2)58 (42.3)
Ever stung before the reaction, n (%)38 (86.4)102 (74.5)NS
Other severe Hymenoptera reactions, n (%)2 (4.5)11 (8)NS
Years after the first severe reaction, mean±SD7.7±5.47.3±6.1NS
Having the severe reaction at work, n (%)17 (38.6)23 (16.8)<0.005
Work-related risk of exposure to Hymenoptera, n (%)
 High28 (63.6)46 (33.6)<0.01
 Occasionally high5 (11.4)35 (25.5)
 Low11 (25)56 (40.9)
Self-employed worker, n (%)20 (45.5)38 (27.7)<0.05
  • NS, not significant; VIT, venom immunotherapy.